Precision Promise (PrP) Bayesian platform trial for metastatic pancreatic cancer (mPDAC): Results of the first experimental arm, SM-88 as second line therapy.
Resource Type
Article
Authors
Oberstein, Paul Eliezer ; wang-gillam, Andrea ; Varghese, Anna M. ; Ko, Andrew H. ; Hendifar, Andrew Eugene ; Ocean, Allyson J. ; McGlothlin, Anna ; Graves, Todd ; Berry, Scott M. ; Detry, Michelle A. ; Fitzgerald, Mark ; Bosse, Anna ; Moravek, Cassadie ; Feehan, Kelly ; Howland, Carrie Meghann ; Berry, Donald A. ; Simeone, Diane M. ; Picozzi, Vincent J.
Source
Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p675-675, 117p
Subject
Language
ISSN
0732183X